We are monitoring the impact of COVID-19 on Wearable Injectors Market Get in touch with us for detailed analysis Know More
Pulished Date May, 2021
ID: 11585
Share on
Share on

Global Wearable Injectors Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Type, Technology, Application, End-user, & Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa)- Industry Forecast (2021 to 2026)

Pulished: May, 2021
ID: 11585
Pages: 190

Global Wearable Injectors Market Size (2021 to 2026)

The global wearable injectors market size is estimated to be growing at a CAGR of 20.02% between 2021 to 2026 and worth USD 15.5 billion by 2026.

Wearable injectors are the kind of injectors that deliver a large volume of drugs subcutaneously. It is sometimes referred to as bolus injectors or patch pumps. It is delivered within the time frame specified, and once properly injected, it is removed from the body and disposed of. Doctors have faced difficulties in supplying more than 1mL and at speeds faster than 20 seconds; wearable injectors are the best solution for this problem. This is essentially adhesively attached to the patients' skin and delivers even viscous medications that vials and syringes cannot deliver in a user-friendly manner. Also, these injectors are personalized based on the patient's preferences and provide bearable pain during administration; thus, more patients are now opting for the wearable injectors method. Wearable injectors are composed of a cartridge, drug contact components, and a rigid needle or a soft cannula.

MARKET DRIVERS:

Rising cases of chronic diseases and demand for biologics associated with the demand for self-administration are expected to drive the global wearable injectors market.

The rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disease drives the wearable injectors market. Chronic conditions necessitate regular injections that can be given daily or weekly, so patients need injections that can be given every 2-6 months. However, this kind of injection involves many medications, which can only be met by wearable injections that administer 2 – 10 ml of medication. According to the National Health Interview Survey (NHIS), about 51.8 % of US adults have one chronic disease, while 27.2 % have several chronic illnesses. According to the WHO, chronic illnesses are responsible for almost 38 million deaths worldwide per year. According to the IDF Diabetes Atlas Ninth Edition 2019, about 463 million adults (20-79 years) have diabetes. This number is expected to grow to 700 million by 2045, with 79 % of adults with diabetes residing in low- and middle-income countries. In addition, according to the World Health Organization, cancer is the leading cause of death worldwide, accounting for almost 10 million deaths in 2020, while the American Cancer Society journal predicts that in 2021, there will be a record 1.9 million new cancer cases diagnosed and 608,570 cancer deaths in the United States. Furthermore, according to WHO, cardiovascular diseases (CVDs) are the leading cause of death worldwide, affecting an estimated 17.9 million lives per year; as this number of cases increases, the need for advanced technological injections like wearable injections increases.

Increased demand for biologics and patient demand for self-administration boost the market growth of wearable injectors.

Biologics are usually delivered intravenously, subcutaneously, or intramuscularly and are not appropriate for oral administration. As a result, as the market for biologics grows, so does the demand for wearable injectors. Besides, many individuals around the world suffer from rare diseases that new biologic methods can help. Wearable injectors are one solution that allows these patients to self-administer the biologics rather than attending hospitals. In addition, patient-centric biologics and their transition from intravenous (IV) infusion to subcutaneous injection drive up demand for wearable injectors.

MARKET RESTRAINTS:

The availability of alternative methods is expected to restrain the global wearable injectors market growth.

The use of alternative drug delivery options is impeding the demand for wearable injectors. Since injectables are painful, patients choose other routes such as oral, topical, and nasal. Most patients favored the oral medication path since it is more cost-effective, reliable, and simple to use. In contrast, patients are not completely trained and secure about injectables, so they choose other routes. Furthermore, wearable injectors necessitate specialist supervision and hospital appointments, resulting in a steady reduction in demand for wearable injectors.

Impact of COVID-19 on the global wearable injectors market:

Covid – 19 began in 2019, and since then, all countries have imposed lockdowns and travel bans. Due to the lack of transportation, many patients opt for self-administering methods at home, such as wearable injectors, particularly in chronic diseases that necessitate repeated injections. Furthermore, the number of people and deaths is growing, putting additional strain on the healthcare system. All hospitals work hard to treat coronavirus patients, and they use wearable injectables that will last for six months. As a result, demand for wearable injectors rises in the face of covid – 19 pandemics.

In addition, to satisfy the increased need for wearable injectors, several companies are producing wearable injectors and expanding their facilities. Becton Dickinson, for example, raised $1.2 billion to expand its market, which increased BD's manufacturing capabilities and upgraded production technology for prefillable syringes and advanced drug delivery systems. This money would advance BD's Libertas wearable injector, a cutting-edge drug delivery device. This contributes to the advancement of wearable injectors.

However, the coronavirus pandemic poses certain difficulties for wearable injectors. Many wearable injectors are still in the development phase, indicating that these devices are in progress. More than 25 high-volume wearable injectors, besides insulin, are currently available or in progress for drug administration. However, the coronavirus pandemic has a negative impact on the planned investments in clinical trials for these injectors, and development has either slowed or stopped.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2020 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Covered

By Type, Technology, Application, End-User, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This research report on the global wearable injectors market has been segmented and sub-segmented based on type, technology, application, end-user, and region.

Global Wearable Injectors Market – By Type:

  • On-body
  • Off-body

Based on the type, the On-body segment is expected to continue its dominance during the forecast period. On-body injectors provide comfort and ease of use, water-resistance and flexible dosing options, and the ability to reheat refrigerated medications automatically. On-body injectors have become more popular as a result of these advantages. The On-body Injector is often inserted on the stomach or behind the arm. A nurse normally gives it on the last day of each chemotherapy cycle. As a result, one of the key market drivers is the growth in the occurrence of cancer and cardiac ailments.

Furthermore, due to the fact that these devices are free of the concerns of skin fitting issues and allergic skin reactions, the market for Off-body injectors is expected to grow at a quicker rate throughout the forecast period.

Global Wearable Injectors Market – By Technology:

  • Spring-based
  • Motor-driven
  • Rotary Pump
  • Expanding Battery
  • Others

Based on the technology, in 2020, the Spring-based segment dominated the market, and it is expected to continue to do that throughout the forecast period. This is due to the growing popularity of adhesive patches, which are user-friendly devices that allow patients to accurately deliver drugs subcutaneously by pressing one or more buttons on the device.

Due to rising customer demand for these devices, which are more comfortable to use than others, the motor-driven segment is predicted to grow at the fastest rate over the forecast period.

Global Wearable Injectors Market – By Application:

  • Oncology
  • Infectious Diseases
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Others

Based on the application, Due to the increased incidence of diabetes and the increasing acceptance of wearable injectors due to their competitive advantage over insulin pumps, the Autoimmune diseases segment is predicted to be the fastest-growing segment throughout the forecast period.

Global Wearable Injectors Market – By End-use:

  • Hospitals
  • Clinics
  • Home Care
  • Others

Based on the end-user, the Homecare category is expected to maintain its dominance during the forecast period. This is related to the growing demand for self-medication and the growing desire to reduce healthcare expenses. In addition, the market is predicted to rise due to the rising demand for technologically developed medication delivery, which reduces hospitalization rates and needs minimal expertise.

Due to an increase in the number of patients who require hospitalization, the Hospitals segment is predicted to rise significantly throughout the forthcoming years. Furthermore, the industry is expected to be driven by the growing number of hospitals throughout the world.

Global Wearable Injectors Market – By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

Based on region, the global wearable injectors market is currently led by North America, which is predicted to account for the highest share of the market in 2020. The market for wearable injectors in North America is predicted to expand due to factors such as the increased incidence of chronic diseases, favorable reimbursement scenarios, and the presence of significant industry participants in the region. According to the American Diabetes Association, diabetes has a greater health impact on Americans than heart disease, substance use disorder, or COPD, with 30.5 million people diagnosed and millions more at risk. The rising frequency of these diseases is projected to fuel demand for wearable injectors throughout the region.

The Asia Pacific is predicted to be the fastest-growing regional market throughout the forecast period. This can be attributed to the region's growing elderly population, particularly in Japan, a large diabetic population in China, and a rise in chronic diseases.

KEY MARKET PARTICIPANTS:

Some of the promising companies operating in the global wearable injectors market profiled in this report are Amgen, Becton, and Dickinson and Company, Medtronic, Valeritas, Inc, Insulet Corporation, Gerresheimer AG (Sensile Medical), Tandem Diabetes Care, SteadyMed Therapeutics, Inc., United Therapeutic Corporation, Sensile Medical AG, Zealand Pharma A/S (Valeritas, Inc.), West Pharmaceutical Services, Inc., SteadyMed Therapeutics, F. Hoffmann-La Roche Ltd, Ypsomed, Johnson & Johnson,  Dexcom, Inc., Enable Injections, CeQur SA, Sensile Medicals, Bespak, and many others.

These players focus on various strategies like product launch, partnerships, acquisitions, and geographic expansion to gain a competitive advantage. These include, On 4 February 2021, Phillips-Medisize and MedTech devices are collaborating with Subcuject, a leading innovator of proprietary device platforms, to deliver a groundbreaking wearable bolus injector that is low-cost, patient-friendly, and prefilled for single-use. Additionally, on 14 July 2020, Sorrel Medical, a company specializing in the development of wearable drug delivery systems, has opened a new manufacturing facility in Israel that will produce wearable injectors. Sorrel's wearable injectors allow clinical trials for large volume and high viscosity drugs in homecare settings.

  1. Introduction                                                          
    1. Market Definition                                               
    2. Scope of the report                                            
    3. Study Assumptions                                            
    4. Base Currency, Base Year and Forecast Periods                                                     
  2. Research Methodology                                                                    
    1. Analysis Design                                                   
    2. Research Phases                                                 
      1. Secondary Research                                       
      2. Primary Research                              
      3. Data Modelling                                 
      4. Expert Validation                              
    3. Study Timeline                                                    
  3. Report Overview                                                                 
    1. Executive Summary                                           
    2. Key Inferences                                                  
  4. Market Dynamics                                                                
    1. Impact Analysis                                                   
      1. Drivers                                  
      2. Restraints                              
      3. Opportunities                                    
    2. Regulatory Environment                                                  
    3. Technology Timeline & Recent Trends                                                      
  5. Competitor Benchmarking Analysis                                                             
    1. Key Player Benchmarking                                                
      1. Market share analysis                                    
      2. Products/Service                              
      3. Regional Presence                            
    2. Mergers & Acquisition Landscape                                                
    3. Joint Ventures & Collaborations                                                  
  6. Market Segmentation                                                                       
    1. Wearable Injectors Market, By Type
      1. On-body
      2. Off-body
      3. Market Size Estimations & Forecasts (2021-2026)                               
      4. Y-o-Y Growth Rate Analysis                                         
      5. Market Attractiveness Index                                       
    2. Wearable Injectors Market, By Technology                                                   
      1. Spring-based
      2. Motor-driven
      3. Rotary Pump
      4. Expanding Battery
      5. Other
      6. Market Size Estimations & Forecasts (2021-2026)                               
      7. Y-o-Y Growth Rate Analysis                                         
      8. Market Attractiveness Index        
    3. Wearable Injectors Market, By Application
      1. Oncology
      2. Infectious Diseases
      3. Cardiovascular Diseases
      4. Autoimmune Diseases
      5. Others
      6.          Market Size Estimations & Forecasts (2021-2026)                               
      7. Y-o-Y Growth Rate Analysis                                         
      8. Market Attractiveness Index               
    4. Wearable Injectors Market, By End-User                                          
      1. Hospitals
      2. Clinics
      3. Home Care
      4. Others
      5. Market Size Estimations & Forecasts (2021-2026)                               
      6. Y-o-Y Growth Rate Analysis                                         
      7. Market Attractiveness Index                                       
  7. Geographical Landscape                                                                  
    1. Global Wearable Injectors Market, by Region                                            
    2. North America - Market Analysis (2021 to 2026)                                                      
      1. By Country                                         
        1. USA                      
        2. Canada               
    3. Europe                                                   
      1. By Country                                         
        1. UK                        
        2. France                 
        3. Germany                          
        4. Spain                   
        5. Italy                     
        6. Rest of Europe                 
    4. Asia Pacific                                             
      1. By Country                                         
        1. China                  
        2. India                    
        3. Japan                  
        4. South Korea                     
        5. South East Asia                
        6. Australia & NZ                  
        7. Rest of Asia-Pacific                        
    5. Latin America                                                      
      1. By Country                                         
        1. Brazil                   
        2. Argentina                         
        3. Mexico                
        4. Rest of Latin America                   
    6. Middle East and Africa                                                     
      1. By Country                                         
        1. Middle East                      
        2. Africa                  
  8. Key Player Analysis                                                             
    1. Amgen
      1. Business Description                                      
      2. Products/Service                              
      3. Financials                             
      4. SWOT Analysis                                  
      5. Recent Developments                                    
      6. Analyst Overview                              
    2. Becton, and Dickinson and Company
    3. Medtronic
    4. Valeritas, Inc.
    5. Insulet Corporation
    6. Gerresheimer AG (Sensile Medical)
    7. Tandem Diabetes Care
    8. SteadyMed Therapeutics, Inc.
    9. United Therapeutic Corporation
    10. Sensile Medical AG
    11. Zealand Pharma A/S (Valeritas, Inc.)
    12. West Pharmaceutical Services, Inc.
    13. SteadyMed Therapeutics
    14. F. Hoffmann-La Roche Ltd
    15. Ypsomed
    16. Johnson & Johnson
    17. Dexcom, Inc.
    18. Enable Injections
    19. CeQur SA
    20. Sensile Medicals
    21. Bespak
  9. Market Outlook & Investment Opportunities
  10. Appendix
    1. List of Tables
    2. List of Figures
  • Global and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • Segment-level analysis in terms of type, technology, application and end-user along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. Global Wearable Injectors Market, By Region, From 2021 to 2026 (USD Billion)
  2. Global Wearable Injectors Market, By Type, From 2021 to 2026 (USD Billion)
  3. Global On-body Market, By Region, From 2021 to 2026 (USD Billion)
  4. Global Off-body Market, By Region, From 2021 to 2026 (USD Billion)
  5. Global Wearable Injectors Market, By Technology, From 2021 to 2026 (USD Billion)
  6. Global Spring-based Market, By Region, From 2021 to 2026 (USD Billion)
  7. Global Motor-driven Market, By Region, From 2021 to 2026 (USD Billion)
  8. Global Rotary Pump Market, By Region, From 2021 to 2026 (USD Billion)
  9. Global Expanding Battery Market, By Region, From 2021 to 2026 (USD Billion)
  10. Global Others Market, By Region, From 2021 to 2026 (USD Billion)
  11. Global Wearable Injectors Market, By Application, From 2021 to 2026 (USD Billion)
  12. Global Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  13. Global Infectious Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  14. Global Cardiovascular Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  15. Global Autoimmune Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  16. Global Others Market, By Region, From 2021 to 2026 (USD Billion)
  17. Global Wearable Injectors Market, By End-use, From 2021 to 2026 (USD Billion)
  18. Global Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  19. Global Clinics Market, By Region, From 2021 to 2026 (USD Billion)
  20. Global Home Care Market, By Region, From 2021 to 2026 (USD Billion)
  21. Global Others Market, By Region, From 2021 to 2026 (USD Billion)
  22. North America Wearable Injectors Market, By Type, From 2021 to 2026 (USD Billion)
  23. North America On-body Market, By Region, From 2021 to 2026 (USD Billion)
  24. North America Off-body Market, By Region, From 2021 to 2026 (USD Billion)
  25. North America Wearable Injectors Market, By Technology, From 2021 to 2026 (USD Billion)
  26. North America Spring-based Market, By Region, From 2021 to 2026 (USD Billion)
  27. North America Motor-driven Market, By Region, From 2021 to 2026 (USD Billion)
  28. North America Rotary Pump Market, By Region, From 2021 to 2026 (USD Billion)
  29. North America Expanding Battery Market, By Region, From 2021 to 2026 (USD Billion)
  30. North America Others Market, By Region, From 2021 to 2026 (USD Billion)
  31. North America Wearable Injectors Market, By Application, From 2021 to 2026 (USD Billion)
  32. North America Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  33. North America Infectious Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  34. North America Cardiovascular Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  35. North America Autoimmune Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  36. North America Others Market, By Region, From 2021 to 2026 (USD Billion)
  37. North America Wearable Injectors Market, By End-use, From 2021 to 2026 (USD Billion)
  38. North America Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  39. North America Clinics Market, By Region, From 2021 to 2026 (USD Billion)
  40. North America Home Care Market, By Region, From 2021 to 2026 (USD Billion)
  41. North America Others Market, By Region, From 2021 to 2026 (USD Billion)
  42. United States Wearable Injectors Market, By Type, From 2021 to 2026 (USD Billion)
  43. United States Wearable Injectors Market, By Technology, From 2021 to 2026 (USD Billion)
  44. United States Wearable Injectors Market, By Application, From 2021 to 2026 (USD Billion)
  45. United States Wearable Injectors Market, By End-use, From 2021 to 2026 (USD Billion)
  46. Canada Wearable Injectors Market, By Type, From 2021 to 2026 (USD Billion)
  47. Canada Wearable Injectors Market, By Technology, From 2021 to 2026 (USD Billion)
  48. Canada Wearable Injectors Market, By Application, From 2021 to 2026 (USD Billion)
  49. Canada Wearable Injectors Market, By End-use, From 2021 to 2026 (USD Billion)
  50. Europe Wearable Injectors Market, By Type, From 2021 to 2026 (USD Billion)
  51. Europe On-body Market, By Region, From 2021 to 2026 (USD Billion)
  52. Europe Off-body Market, By Region, From 2021 to 2026 (USD Billion)
  53. Europe Wearable Injectors Market, By Technology, From 2021 to 2026 (USD Billion)
  54. Europe Spring-based Market, By Region, From 2021 to 2026 (USD Billion)
  55. Europe Motor-driven Market, By Region, From 2021 to 2026 (USD Billion)
  56. Europe Rotary Pump Market, By Region, From 2021 to 2026 (USD Billion)
  57. Europe Expanding Battery Market, By Region, From 2021 to 2026 (USD Billion)
  58. Europe Others Market, By Region, From 2021 to 2026 (USD Billion)
  59. Europe Wearable Injectors Market, By Application, From 2021 to 2026 (USD Billion)
  60. Europe Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  61. Europe Infectious Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  62. Europe Cardiovascular Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  63. Europe Autoimmune Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  64. Europe Others Market, By Region, From 2021 to 2026 (USD Billion)
  65. Europe Wearable Injectors Market, By End-use, From 2021 to 2026 (USD Billion)
  66. Europe Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  67. Europe Clinics Market, By Region, From 2021 to 2026 (USD Billion)
  68. Europe Home Care Market, By Region, From 2021 to 2026 (USD Billion)
  69. Europe Others Market, By Region, From 2021 to 2026 (USD Billion)
  70. U.K. Wearable Injectors Market, By Type, From 2021 to 2026 (USD Billion)
  71. U.K. Wearable Injectors Market, By Technology, From 2021 to 2026 (USD Billion)
  72. U.K. Wearable Injectors Market, By Application, From 2021 to 2026 (USD Billion)
  73. U.K. Wearable Injectors Market, By End-use, From 2021 to 2026 (USD Billion)
  74. Germany Wearable Injectors Market, By Type, From 2021 to 2026 (USD Billion)
  75. Germany Wearable Injectors Market, By Technology, From 2021 to 2026 (USD Billion)
  76. Germany Wearable Injectors Market, By Application, From 2021 to 2026 (USD Billion)
  77. Germany Wearable Injectors Market, By End-use, From 2021 to 2026 (USD Billion)
  78. France Wearable Injectors Market, By Type, From 2021 to 2026 (USD Billion)
  79. France Wearable Injectors Market, By Technology, From 2021 to 2026 (USD Billion)
  80. France Wearable Injectors Market, By Application, From 2021 to 2026 (USD Billion)
  81. France Wearable Injectors Market, By End-use, From 2021 to 2026 (USD Billion)
  82. Italy Wearable Injectors Market, By Type, From 2021 to 2026 (USD Billion)
  83. Italy Wearable Injectors Market, By Technology, From 2021 to 2026 (USD Billion)
  84. Italy Wearable Injectors Market, By Application, From 2021 to 2026 (USD Billion)
  85. Italy Wearable Injectors Market, By End-use, From 2021 to 2026 (USD Billion)
  86. Spain Wearable Injectors Market, By Type, From 2021 to 2026 (USD Billion)
  87. Spain Wearable Injectors Market, By Technology, From 2021 to 2026 (USD Billion)
  88. Spain Wearable Injectors Market, By Application, From 2021 to 2026 (USD Billion)
  89. Spain Wearable Injectors Market, By End-use, From 2021 to 2026 (USD Billion)
  90. Asia Pacific Wearable Injectors Market, By Type, From 2021 to 2026 (USD Billion)
  91. Asia Pacific On-body Market, By Region, From 2021 to 2026 (USD Billion)
  92. Asia Pacific Off-body Market, By Region, From 2021 to 2026 (USD Billion)
  93. Asia Pacific Wearable Injectors Market, By Technology, From 2021 to 2026 (USD Billion)
  94. Asia Pacific Spring-based Market, By Region, From 2021 to 2026 (USD Billion)
  95. Asia Pacific Motor-driven Market, By Region, From 2021 to 2026 (USD Billion)
  96. Asia Pacific Rotary Pump Market, By Region, From 2021 to 2026 (USD Billion)
  97. Asia Pacific Expanding Battery Market, By Region, From 2021 to 2026 (USD Billion)
  98. Asia Pacific Others Market, By Region, From 2021 to 2026 (USD Billion)
  99. Asia Pacific Wearable Injectors Market, By Application, From 2021 to 2026 (USD Billion)
  100. Asia Pacific Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  101. Asia Pacific Infectious Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  102. Asia Pacific Cardiovascular Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  103. Asia Pacific Autoimmune Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  104. Asia Pacific Others Market, By Region, From 2021 to 2026 (USD Billion)
  105. Asia Pacific Wearable Injectors Market, By End-use, From 2021 to 2026 (USD Billion)
  106. Asia Pacific Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  107. Asia Pacific Clinics Market, By Region, From 2021 to 2026 (USD Billion)
  108. Asia Pacific Home Care Market, By Region, From 2021 to 2026 (USD Billion)
  109. Asia Pacific Others Market, By Region, From 2021 to 2026 (USD Billion)
  110. Japan Wearable Injectors Market, By Type, From 2021 to 2026 (USD Billion)
  111. Japan Wearable Injectors Market, By Technology, From 2021 to 2026 (USD Billion)
  112. Japan Wearable Injectors Market, By Application, From 2021 to 2026 (USD Billion)
  113. Japan Wearable Injectors Market, By End-use, From 2021 to 2026 (USD Billion)
  114. China Wearable Injectors Market, By Type, From 2021 to 2026 (USD Billion)
  115. China Wearable Injectors Market, By Technology, From 2021 to 2026 (USD Billion)
  116. China Wearable Injectors Market, By Application, From 2021 to 2026 (USD Billion)
  117. China Wearable Injectors Market, By End-use, From 2021 to 2026 (USD Billion)
  118. India Wearable Injectors Market, By Type, From 2021 to 2026 (USD Billion)
  119. India Wearable Injectors Market, By Technology, From 2021 to 2026 (USD Billion)
  120. India Wearable Injectors Market, By Application, From 2021 to 2026 (USD Billion)
  121. India Wearable Injectors Market, By End-use, From 2021 to 2026 (USD Billion)
  122. Australia Wearable Injectors Market, By Type, From 2021 to 2026 (USD Billion)
  123. Australia Wearable Injectors Market, By Technology, From 2021 to 2026 (USD Billion)
  124. Australia Wearable Injectors Market, By Application, From 2021 to 2026 (USD Billion)
  125. Australia Wearable Injectors Market, By End-use, From 2021 to 2026 (USD Billion)
  126. South Korea Wearable Injectors Market, By Type, From 2021 to 2026 (USD Billion)
  127. South Korea Wearable Injectors Market, By Technology, From 2021 to 2026 (USD Billion)
  128. South Korea Wearable Injectors Market, By Application, From 2021 to 2026 (USD Billion)
  129. South Korea Wearable Injectors Market, By End-use, From 2021 to 2026 (USD Billion)
  130. Latin America Wearable Injectors Market, By Type, From 2021 to 2026 (USD Billion)
  131. Latin America On-body Market, By Region, From 2021 to 2026 (USD Billion)
  132. Latin America Off-body Market, By Region, From 2021 to 2026 (USD Billion)
  133. Latin America Wearable Injectors Market, By Technology, From 2021 to 2026 (USD Billion)
  134. Latin America Spring-based Market, By Region, From 2021 to 2026 (USD Billion)
  135. Latin America Motor-driven Market, By Region, From 2021 to 2026 (USD Billion)
  136. Latin America Rotary Pump Market, By Region, From 2021 to 2026 (USD Billion)
  137. Latin America Expanding Battery Market, By Region, From 2021 to 2026 (USD Billion)
  138. Latin America Others Market, By Region, From 2021 to 2026 (USD Billion)
  139. Latin America Wearable Injectors Market, By Application, From 2021 to 2026 (USD Billion)
  140. Latin America Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  141. Latin America Infectious Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  142. Latin America Cardiovascular Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  143. Latin America Autoimmune Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  144. Latin America Others Market, By Region, From 2021 to 2026 (USD Billion)
  145. Latin America Wearable Injectors Market, By End-use, From 2021 to 2026 (USD Billion)
  146. Latin America Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  147. Latin America Clinics Market, By Region, From 2021 to 2026 (USD Billion)
  148. Latin America Home Care Market, By Region, From 2021 to 2026 (USD Billion)
  149. Latin America Others Market, By Region, From 2021 to 2026 (USD Billion)
  150. Brazil Wearable Injectors Market, By Type, From 2021 to 2026 (USD Billion)
  151. Brazil Wearable Injectors Market, By Technology, From 2021 to 2026 (USD Billion)
  152. Brazil Wearable Injectors Market, By Application, From 2021 to 2026 (USD Billion)
  153. Brazil Wearable Injectors Market, By End-use, From 2021 to 2026 (USD Billion)
  154. Argentina Wearable Injectors Market, By Type, From 2021 to 2026 (USD Billion)
  155. Argentina Wearable Injectors Market, By Technology, From 2021 to 2026 (USD Billion)
  156. Argentina Wearable Injectors Market, By Application, From 2021 to 2026 (USD Billion)
  157. Argentina Wearable Injectors Market, By End-use, From 2021 to 2026 (USD Billion)
  158. Mexico Wearable Injectors Market, By Type, From 2021 to 2026 (USD Billion)
  159. Mexico Wearable Injectors Market, By Technology, From 2021 to 2026 (USD Billion)
  160. Mexico Wearable Injectors Market, By Application, From 2021 to 2026 (USD Billion)
  161. Mexico Wearable Injectors Market, By End-use, From 2021 to 2026 (USD Billion)
  162. Rest of Latin America Wearable Injectors Market, By Type, From 2021 to 2026 (USD Billion)
  163. Rest of Latin America Wearable Injectors Market, By Technology, From 2021 to 2026 (USD Billion)
  164. Rest of Latin America Wearable Injectors Market, By Application, From 2021 to 2026 (USD Billion)
  165. Rest of Latin America Wearable Injectors Market, By End-use, From 2021 to 2026 (USD Billion)
  166. Middle East and Africa Wearable Injectors Market, By Type, From 2021 to 2026 (USD Billion)
  167. Middle East and Africa On-body Market, By Region, From 2021 to 2026 (USD Billion)
  168. Middle East and Africa Off-body Market, By Region, From 2021 to 2026 (USD Billion)
  169. Middle East and Africa Wearable Injectors Market, By Technology, From 2021 to 2026 (USD Billion)
  170. Middle East and Africa Spring-based Market, By Region, From 2021 to 2026 (USD Billion)
  171. Middle East and Africa Motor-driven Market, By Region, From 2021 to 2026 (USD Billion)
  172. Middle East and Africa Rotary Pump Market, By Region, From 2021 to 2026 (USD Billion)
  173. Middle East and Africa Expanding Battery Market, By Region, From 2021 to 2026 (USD Billion)
  174. Middle East and Africa Others Market, By Region, From 2021 to 2026 (USD Billion)
  175. Middle East and Africa Wearable Injectors Market, By Application, From 2021 to 2026 (USD Billion)
  176. Middle East and Africa Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  177. Middle East and Africa Infectious Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  178. Middle East and Africa Cardiovascular Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  179. Middle East and Africa Autoimmune Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  180. Middle East and Africa Others Market, By Region, From 2021 to 2026 (USD Billion)
  181. Middle East and Africa Wearable Injectors Market, By End-use, From 2021 to 2026 (USD Billion)
  182. Middle East and Africa Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  183. Middle East and Africa Clinics Market, By Region, From 2021 to 2026 (USD Billion)
  184. Middle East and Africa Home Care Market, By Region, From 2021 to 2026 (USD Billion)
  185. Middle East and Africa Others Market, By Region, From 2021 to 2026 (USD Billion)
  186. Middle East Wearable Injectors Market, By Type, From 2021 to 2026 (USD Billion)
  187. Middle East Wearable Injectors Market, By Technology, From 2021 to 2026 (USD Billion)
  188. Middle East Wearable Injectors Market, By Application, From 2021 to 2026 (USD Billion)
  189. Middle East Wearable Injectors Market, By End-use, From 2021 to 2026 (USD Billion)
  190. Africa Wearable Injectors Market, By Type, From 2021 to 2026 (USD Billion)
  191. Africa Wearable Injectors Market, By Technology, From 2021 to 2026 (USD Billion)
  192. Africa Wearable Injectors Market, By Application, From 2021 to 2026 (USD Billion)
  193. Africa Wearable Injectors Market, By End-use, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample